[1]
“Beta-blockers in chronic obstructive pulmonary disease: Risk or benefit?”, Rev Port Med Geral Fam, vol. 26, no. 5, pp. 517–8, Sep. 2010, doi: 10.32385/rpmgf.v26i5.10788.